<SEC-DOCUMENT>0000950103-25-014736.txt : 20251114
<SEC-HEADER>0000950103-25-014736.hdr.sgml : 20251114
<ACCEPTANCE-DATETIME>20251114121649
ACCESSION NUMBER:		0000950103-25-014736
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20251114
DATE AS OF CHANGE:		20251114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251483331

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp237377_424b2-8036wfpps.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #DE1A1E"><B>The information in this preliminary
pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus, prospectus
supplement and product supplement do not constitute an offer to sell the securities and we are not soliciting an offer to buy the securities
in any state where the offer or sale is not permitted.</B></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #DE1A1E">Subject to Completion. Dated
November 14, 2025</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">PRICING SUPPLEMENT dated November&nbsp;&nbsp;&nbsp;&nbsp;,
    2025</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">(To the Prospectus dated May 15, 2025,</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">the Prospectus Supplement dated May 15, 2025 and</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">the Product Supplement No. WF-1 dated May 20, 2025)</P></TD>
    <TD STYLE="width: 47%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Filed Pursuant to Rule 424(b)(2)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">Registration Statement No. 333-287303</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_004.jpg" ALT="barclays PLC logo" STYLE="height: 42px; width: 179px"></FONT></P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="padding-left: 4.3; width: 100%">
    <P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left; color: #BB0826">Global Medium-Term Notes, Series A</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="padding-left: 4.3">
    <P STYLE="color: #BB0826; font: bold 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed
    Return and Contingent Downside</P>
    <P STYLE="color: #BB0826; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Principal at Risk Securities
    Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</P></TD></TR>
  </TABLE>
<DIV STYLE="background-color: rgb(104,143,207)">

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="color: White"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.3pt"></TD><TD STYLE="width: 13.7pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Linked
                                            to the common stock of Micron Technology, Inc. (the &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.5pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Unlike
                                            ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal
                                            at maturity. Instead, the securities provide for a maturity payment amount that may be greater
                                            than or less than the principal amount of the securities, depending on the performance of
                                            the Underlying Stock from the starting price to the ending price. The maturity payment amount
                                            will reflect the following terms:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.3pt"></TD><TD STYLE="width: 13.7pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">If
                                            the price of the Underlying Stock increases, remains flat or decreases, but the decrease
                                            is not more than 25%, you will receive the principal amount plus a contingent fixed return
                                            of at least 36.00% (to be determined on the pricing date) of the principal amount.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 22.3pt"></TD><TD STYLE="width: 13.7pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">If
                                            the price of the Underlying Stock decreases by more than 25%, you will have full downside
                                            exposure to the decrease in the price of the Underlying Stock, and you will lose more than
                                            25%, and possibly all, of the principal amount of your securities.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.5pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Investors
                                            may lose more than 25%, and possibly all, of the principal amount.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.5pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Any
                                            positive return on the securities at maturity will be limited to the contingent fixed return,
                                            even if the ending price significantly exceeds the starting price; you will not participate
                                            in any appreciation of the Underlying Stock.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.5pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Any
                                            payment on the securities, including any repayment of principal, is subject to the creditworthiness
                                            of Barclays Bank PLC and is not guaranteed by any third party. If Barclays Bank PLC were
                                            to default on its payment obligations or become subject to the exercise of any U.K. Bail-in
                                            Power (as described on page PPS-6 of this pricing supplement) by the relevant U.K. resolution
                                            authority, you might not receive any amounts owed to you under the securities. See &ldquo;Selected
                                            Risk Considerations&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing
                                            supplement and &ldquo;Risk Factors&rdquo; in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.5pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">No
                                            periodic interest payments or dividends</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: red; font: 10pt Verdana, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 4.5pt"></TD><TD STYLE="width: 13.5pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="text-align: justify; padding-right: 4.3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">No
                                            exchange listing; designed to be held to maturity</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: White"></FONT></P>

</DIV>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">See &ldquo;Additional Information about the
Issuer and the Securities&rdquo; on page PPS-4 of this pricing supplement. The securities will have the terms specified in the prospectus
dated May 15, 2025, the prospectus supplement dated May 15, 2025 and the product supplement no. WF-1 dated May 20, 2025, as supplemented
or superseded by this pricing supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities have complex features and investing
in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk Considerations&rdquo;
on page PPS-9 herein, &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the product supplement and &ldquo;Risk Factors&rdquo; beginning
on page S-9 of the prospectus supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities constitute our unsecured and
unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial
Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit
insurance agency of the United States, the United Kingdom or any other jurisdiction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Neither the U.S. Securities and Exchange Commission
(the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined that
this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PPS-6 of this pricing supplement.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; width: 21%; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 27%; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Original Offering Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 26%; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agent Discount<SUP>(2), (3)</SUP></B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 26%; font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$23.25</FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$976.75</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Georgia, Times, Serif; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">Our estimated value of the securities on the pricing date, based on our internal pricing models, is expected
to be between $907.70 and $957.70 per security. The estimated value is expected to be less than the original offering price of the securities.
See &ldquo;Additional Information Regarding Our Estimated Value of the Securities&rdquo; on page PPS-5 of this pricing supplement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><SUP>(2)</SUP></TD><TD STYLE="text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;) and Barclays Capital Inc. are the agents for the
distribution of the securities and are acting as principal. The agent will receive an underwriting discount of up to $23.25 per security.
Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession not in excess
of $23.25 per security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of
the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network,
LLC), with a selling concession of $17.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of
the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA. See &ldquo;Terms of the Securities&mdash;Supplemental
Plan of Distribution&rdquo; in this pricing supplement for further information.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><SUP>(3)</SUP></TD><TD STYLE="text-align: justify">In respect of certain securities sold in this offering, Barclays Capital Inc. may pay a fee of up to $2.00
per security to selected securities dealers in consideration for marketing and other services in connection with the distribution of the
securities to other securities dealers.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: bold 12pt Arial, Helvetica, Sans-Serif; width: 50%; text-align: justify">Wells Fargo Securities</TD>
    <TD STYLE="font: bold 12pt Arial, Helvetica, Sans-Serif; width: 50%; text-align: right">Barclays Capital Inc.</TD></TR>
  </TABLE>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; color: #BB0826; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Terms
of the Securities</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 2pt; border: white 1.5pt solid; width: 21%; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; width: 79%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Market Measure<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The common stock of Micron Technology, Inc. (Bloomberg ticker symbol &ldquo;MU UW&lt;Equity&gt;&rdquo;) (the &ldquo;<U>Underlying Stock</U>&rdquo;). We refer to the issuer of the Underlying Stock as the &ldquo;<U>Underlying Stock Issuer.</U>&rdquo;</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">November 18, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">November 21, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Calculation Day<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">December 2, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Stated Maturity Date<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">December 7, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: black"><B>Maturity Payment Amount: </B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will be entitled
    to receive a cash payment per security in U.S. dollars equal to the maturity payment amount. The &ldquo;<U>maturity payment amount</U>&rdquo;
    per security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Symbol; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#183;</P>
    <P STYLE="font: 10pt Symbol; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">if the ending price
    is greater than or equal to the threshold price:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">$1,000 + the contingent fixed return; or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>
    <P STYLE="font: 10pt Symbol; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#183;</P>
    <P STYLE="font: 10pt Symbol; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">if the ending price
    is less than the threshold price:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">$1,000 + ($1,000 &times; stock return)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the ending price is less than the threshold
    price, you will lose more than 25%, and possibly all, of the principal amount of your securities at maturity. Any payment on the securities,
    including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party.
    If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power by the relevant
    U.K. resolution authority, you might not receive any amounts owed to you under the securities.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Contingent Fixed Return:</B></FONT></TD>
    <TD STYLE="padding: 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>contingent fixed return</U>&rdquo; will be determined on the pricing date and will be at least 36.00% of the principal amount (at least $360.00 per security). The contingent fixed return is payable only if the ending price is greater than or equal to the threshold price.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Threshold Price:</B></FONT></TD>
    <TD STYLE="padding: 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which is equal to 75% of the starting price</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Return:</B></FONT></TD>
    <TD STYLE="padding: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;<U>stock return</U>&rdquo; is the percentage
    change from the starting price to the ending price, measured as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><U>ending price &ndash; starting price</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.75in; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;starting
    price</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: 0.5in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Starting Price:</B></FONT></TD>
    <TD STYLE="padding: 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which is the stock closing price of the Underlying Stock on the pricing date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ending Price:</B></FONT></TD>
    <TD STYLE="padding: 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>ending price</U>&rdquo; will be the stock closing price of the Underlying Stock on the calculation day.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Closing Price<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;&ldquo;<U>Stock closing price</U>&rdquo; has the meaning set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Certain Definitions&rdquo; in the product supplement. The stock closing price of the Underlying Stock is subject to adjustment through the adjustment factor as described in the product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Additional Terms:</B></FONT></TD>
    <TD STYLE="padding: 2pt; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Terms used in this pricing supplement, but not defined herein, will have the meanings ascribed to them in the product supplement, <I>provided</I> that terms used in this pricing supplement, but not defined herein or in the product supplement, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding: 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Tax Considerations:</B></FONT></TD>
    <TD STYLE="padding: 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For a discussion of the tax considerations relating to ownership and disposition of the securities, see &ldquo;Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding: 2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border: white 1.5pt solid; width: 21%; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="padding: 2pt; width: 79%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">06746EQY4 / US06746EQY40</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt; border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Supplemental Plan of Distribution:</B></FONT></TD>
    <TD STYLE="padding: 2pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;)
    and Barclays Capital Inc. will act as agents for the securities. The agent will receive an underwriting discount of up to $23.25 per security.
    Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession not in excess
    of $23.25 per security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of
    the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network,
    LLC), with a selling concession of $17.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of
    the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in respect of certain securities
    sold in this offering, Barclays may pay a fee of up to $2.00 per security to selected securities dealers in consideration for marketing
    and other services in connection with the distribution of the securities to other securities dealers.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC or its affiliate will enter
    into swap agreements or related hedge transactions with one of its other affiliates or unaffiliated counterparties in connection with
    the sale of the securities. If WFS, Barclays Capital Inc. or an affiliate of either agent participating as a dealer in the distribution
    of the securities conducts hedging activities for Barclays Bank PLC in connection with the securities, such agent or participating dealer
    will expect to realize a projected profit from such hedging activities, and this projected profit will be in addition to any discount,
    concession or fee received in connection with the sale of the securities to you. This additional projected profit may create a further
    incentive for the agents or participating dealers to sell the securities to you.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>


<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>1</SUP> In the case of certain corporate
events related to the Underlying Stock, the calculation agent may adjust the adjustment factor of the Underlying Stock if the calculation
agent determines that the event has a diluting or concentrative effect on the theoretical value of the shares of the Underlying Stock.
Upon the occurrence of certain reorganization events with respect to the Underlying Stock, the calculation agent will make adjustments
to reflect the amount and type of property deliverable for one share of the Underlying Stock as a result of that reorganization event.
The Underlying Stock may be replaced with another stock selected by the calculation agent upon the occurrence of certain replacement stock
events. For more information, see &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment
Events&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>2</SUP> If the calculation day is not a trading
day, the calculation day will be postponed to the next succeeding trading day. The calculation day will also be postponed if a market
disruption event occurs on the calculation day as described under &ldquo;General Terms of the Securities&mdash;Consequences of a Market
Disruption Event; Postponement of a Calculation Day&mdash;Securities Linked to a Single Market Measure&rdquo; in the accompanying product
supplement. In addition, the stated maturity date will be postponed if that day is not a business day or if the calculation day is postponed
as described under &ldquo;General Terms of the Securities&mdash;Payment Dates&rdquo; in the accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information about the Issuer and the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term
Notes, Series A, of which these securities are a part and the product supplement no. WF-1 dated May 20, 2025. This pricing supplement,
together with the documents listed below, contains the terms of the securities and supersedes all prior or contemporaneous oral statements
as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for
implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things,
the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Selected Risk Considerations&rdquo; in
this pricing supplement, as the securities involve risks not associated with conventional debt securities. We urge you to consult your
investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the information or terms in this
pricing supplement are different from or inconsistent with the information or terms in the prospectus, prospectus supplement or product
supplement, the information and terms in this pricing supplement will control. To the extent the information or terms in the product supplement
are different from or inconsistent with the information or terms in the prospectus or prospectus supplement, the information and terms
in the product supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus dated May 15, 2025:<BR>
</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus Supplement dated May 15, 2025:<BR>
</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product Supplement No. WF-1 dated May 20, 2025:<BR>
</FONT><A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Additional
Information Regarding Our Estimated Value of the Securities</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The final terms for the securities will be determined
on the date the securities are initially priced for sale to the public (the &ldquo;<U>pricing date</U>&rdquo;) based on prevailing market
conditions on or prior to the pricing date and will be communicated to investors orally and/or in a final pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our internal pricing models take into account
a number of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility,
interest rates and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on
variables, such as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels
at which our benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal
funding rates. Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value of the securities on the pricing
date is expected to be less than the original offering price of the securities. The difference between the original offering price of
the securities and our estimated value of the securities is expected to result from several factors, including any sales commissions expected
to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to
be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection
with structuring the securities, the estimated cost that we may incur in hedging our obligations under the securities, and estimated development
and other costs that we may incur in connection with the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value on the pricing date is not
a prediction of the price at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital
Inc. may buy or sell the securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or
another affiliate of ours intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming that all relevant factors remain constant
after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if
any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may
exceed our estimated value on the pricing date for a temporary period expected to be approximately three months after the initial issue
date of the securities because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost
of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur
over the term of the securities. We made such discretionary election and determined this temporary reimbursement period on the basis of
a number of factors, which may include the tenor of the securities and/or any agreement we may have with the distributors of the securities.
The amount of our estimated costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement
period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue
date of the securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to read the &ldquo;Selected Risk
Considerations&rdquo; beginning on page PPS-9 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You may revoke your offer to purchase the securities
at any time prior to the pricing date. We reserve the right to change the terms of, or reject any offer to purchase, the securities prior
to their pricing date. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept
such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Consent
to U.K. Bail-in Power</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial owner of
the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner
of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the U.K. Banking Act 2009, as amended, the
relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority
is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely
to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;<U>FSMA</U>&rdquo;) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (&ldquo;<U>EEA</U>&rdquo;) or third country institution or investment firm, that the relevant EEA or third
country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.K. Bail-in Power includes any write-down,
conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations
of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares,
securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities,
or the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please see &ldquo;Selected
Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is
Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is
failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers,
could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Investor
Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek a contingent fixed return at maturity
of at least 36.00% (to be provided in the pricing supplement) of the principal amount if the ending price is greater than or equal to
the threshold price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You anticipate that the ending price will be
greater than or equal to the threshold price, and you are willing and able to accept the risk that, if it is not, you will lose more than
25%, and possibly all, of the principal amount of your securities at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand that if the ending price is greater
than or equal to the threshold price, the return you will receive at maturity will be limited to the contingent fixed return, regardless
of whether, and the extent to which, the ending price exceeds the starting price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the risks
associated with an investment linked to the performance of the Underlying Stock, as explained in more detail in the &ldquo;Selected Risk
Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand and accept that you will not be
entitled to receive dividends or distributions that may be paid to holders of the Underlying Stock, nor will you have any voting rights
with respect to the Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment for which there
will be an active secondary market and you are willing and able to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to consent to the exercise
of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may <I>not</I> be an appropriate
investment for you if <I>any</I> of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for the
full repayment of principal at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You anticipate that the ending price will be
less than the threshold price, or you are unwilling or unable to accept the risk that, if it is, you will lose more than 25%, and possibly
all, of the principal amount of your securities at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for full
exposure to the upside performance of the Underlying Stock above the contingent fixed return.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the risks
associated with an investment linked to the performance of the Underlying Stock, as explained in more detail in the &ldquo;Selected Risk
Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that entitles you to dividends
or distributions on, or voting rights related to, the Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment for which there will be
an active secondary market and/or you are unwilling or unable to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#167;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to consent to the
exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an investment in the securities in light of your particular circumstances. You should also review carefully the
&ldquo;Selected Risk Considerations&rdquo; beginning on page PPS-9 of this pricing supplement and the &ldquo;Risk Factors&rdquo; beginning
on page PS-3 of the accompanying product supplement and the &ldquo;Risk Factors&rdquo; beginning on page S-9 of the accompanying prospectus
supplement for risks related to an investment in the securities. For more information about the Underlying Stock, please see the section
titled &ldquo;The Common Stock of Micron Technology, Inc.&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Determining
the Maturity Payment Amount</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will receive
a cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_005.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Selected
Risk Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. Investing in the securities is not equivalent to investing directly in the Underlying Stock. Some of the risks that apply to an
investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relating to the securities
generally in the &ldquo;Risk Factors&rdquo; sections of the product supplement and prospectus supplement. You should not purchase the
securities unless you understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Securities
Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>If The Ending Price Is Less Than The Threshold
Price, You Will Lose More Than 25%, And Possibly All, Of The Principal Amount Of Your Securities At Maturity</B> &mdash; If the ending
price is less than the threshold price, the maturity payment amount will be less than the principal amount and you will have full downside
exposure to the decrease in the price of the Underlying Stock from the starting price. The threshold price for the Underlying Stock is
75% of the starting price. For example, if the Underlying Stock has declined by 25.1% from the starting price to the ending price, you
will not receive any benefit from the contingent downside feature and you will lose 25.1% of the principal amount. As a result, you will
not receive any protection if the price of the Underlying Stock declines significantly and you may lose more than 25%, and possibly all,
of the principal amount at maturity, even if the price of the Underlying Stock is greater than or equal to the starting price or the threshold
price at certain times during the term of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>The Potential Return
On The Securities Is Limited To The Contingent Fixed Return And May Be Lower Than The Return On A Direct Investment In The Underlying
Stock </B>&mdash; The potential return on the securities is limited to the contingent fixed return, regardless of any appreciation of
the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Underlying Stock<FONT STYLE="background-color: white">, which may
be significant. Therefore, your return on the securities may be lower than the return on a direct investment in the </FONT>Underlying
Stock<FONT STYLE="background-color: white">.</FONT></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>You Will Receive
The Contingent Fixed Return Only If The Ending Price Is Greater Than Or Equal To The Threshold Price </B>&mdash; You will receive the
contingent fixed return only if the ending price is greater than or equal to the threshold price. If the ending price is less than the
threshold price, then you will not receive the contingent fixed return, and you will suffer a loss on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Periodic Interest Will Be Paid On The Securities
</B>&mdash; No periodic payments of interest will be made on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Any Payment On The Securities Will Be Determined
Based On The Stock Closing Prices Of The Underlying Stock On The Dates Specified</B> &mdash; Any payment on the securities will be determined
based on the stock closing prices of the Underlying Stock on the dates specified. You will not benefit from any more favorable values
of the Underlying Stock determined at any other time. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Owning The Securities Is Not The Same As Owning
The Underlying Stock</B> &mdash; The return on your securities may not reflect the return you would realize if you actually owned the
Underlying Stock. For instance, as a holder of the securities, you will not have voting rights or rights to receive cash dividends or
other distributions or any other rights that holders of the Underlying Stock would have.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Assurance That The Investment View Implicit
In The Securities Will Be Successful </B>&mdash; It is impossible to predict whether and the extent to which the price of the Underlying
Stock will rise or fall. There can be no assurance that the ending price will not be less than the threshold price. The price of the Underlying
Stock will be influenced by complex and interrelated political, economic, financial and other factors that affect the Underlying Stock.
You should be willing to accept the downside risks associated with equities in general and the Underlying Stock in particular, and the
risk of losing a significant portion or all of the principal amount. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The U.S. Federal Income Tax Consequences Of
An Investment In The Securities Are Uncertain</B> &mdash; There is no direct legal authority regarding the proper U.S. federal income
tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;). Consequently,
significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of
the securities as prepaid forward contracts, as described below under &ldquo;Tax Considerations.&rdquo; If the IRS were successful in
asserting an alternative treatment for the securities, the tax consequences of the ownership and disposition of the securities could be
materially and adversely affected.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, in 2007
the Treasury Department and the IRS released a notice requesting comments on various issues regarding the U.S. federal income tax treatment
of &ldquo;prepaid forward contracts&rdquo; and similar instruments. Any Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive
effect. You should review carefully the sections of the accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income
Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S.
holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders,&rdquo; and consult your tax advisor regarding the U.S. federal tax consequences
of an investment in the securities (including possible alternative treatments and the issues presented by the 2007 notice), as well as
tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Are Subject To The Credit Risk
Of Barclays Bank PLC</B> &mdash; The securities are unsecured and unsubordinated debt obligations of the issuer, Barclays Bank PLC, and
are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the securities, including any repayment
of principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations as they come due and is not guaranteed by any
third party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the securities
and, in the event Barclays Bank PLC were to default on its obligations, you might not receive any amount owed to you under the terms of
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You May Lose Some Or All Of Your Investment
If Any U.K. Bail-In Power Is Exercised By The Relevant U.K. Resolution Authority &mdash; </B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority as set forth under &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement. Accordingly, any
U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders and beneficial owners of the securities losing
all or a part of the value of your investment in the securities or receiving a different security from the securities, which may be worth
significantly less than the securities and which may have significantly fewer protections than those typically afforded to debt securities.
Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring
the consent of, the holders and beneficial owners of the securities. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority with respect to the securities will not be a default or an Event of Default (as each term is defined in the senior debt securities
indenture) and the trustee will not be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance
with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities. See &ldquo;Consent
to U.K. Bail-in Power&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating
to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail,
including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely
affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms
of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Underlying
Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>There Are Risks Associated With Single Equities
</B>&mdash; The price of the Underlying Stock can rise or fall sharply due to factors specific to the Underlying Stock and its issuer,
such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and
decisions and other events, as well as general market factors, such as general stock market volatility and levels, interest rates and
economic and political conditions. We urge you to review financial and other information filed periodically with the SEC by the issuer
of the Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We Cannot Control Actions By The Underlying
Stock Issuer</B> &mdash; Actions by the Underlying Stock Issuer may have an adverse effect on the price of the Underlying Stock, the ending
price and the value of the securities. We are not affiliated with the Underlying Stock Issuer. The Underlying Stock Issuer will not be
involved in the offering of the securities nor will the Underlying Stock Issuer have any obligations with respect to the securities, including
any obligation to take our interests or your interests into consideration for any reason. The Underlying Stock Issuer will not receive
any of the proceeds of the offering of the securities nor will be responsible for, or will have participated in, the determination of
the timing of, prices for, or quantities of, the securities to be issued. The Underlying Stock Issuer will not be involved with the administration,
marketing or trading of the securities nor will have any obligations with respect to any amounts payable on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We And Our Affiliates Have No Affiliation
With The Underlying Stock Issuer And Have Not Independently Verified Its Public Disclosure Of Information</B> &mdash; We, our affiliates
and WFS and its affiliates are not affiliated in any way with the Underlying Stock Issuer. This pricing supplement relates only to the
securities and does not relate to the Underlying Stock. The material provided in this pricing supplement concerning the Underlying Stock
Issuer is derived from publicly available documents without independent verification. Neither we nor either agent has participated in
the preparation of any of those documents or made any &ldquo;due diligence&rdquo; investigation or any inquiry of the Underlying Stock
Issuer. Furthermore, neither we nor either agent knows whether the Underlying Stock Issuer has disclosed all events occurring before the
date of this pricing supplement, including events that could affect the accuracy or completeness of the publicly available documents referred
to above. Subsequent disclosure of any event of this kind or the disclosure of or failure to disclose material future events concerning
the Underlying Stock Issuer could affect the value of the securities and any payments on the securities. You, as an investor in the securities,
should make your own investigation into the Underlying Stock Issuer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Have Limited Anti-dilution Protection</B>
&mdash; The calculation agent will, in its sole discretion, adjust the adjustment factor of the Underlying Stock for certain events affecting
the Underlying Stock, such as stock splits and stock dividends, and certain other corporate actions involving the Underlying Stock Issuer,
such as mergers. However, the calculation agent is not required to make an adjustment for every corporate event that can affect the Underlying
Stock. For example, the calculation agent is not required to make </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">any adjustments to
the adjustment factor of the Underlying Stock if the Underlying Stock Issuer or anyone else makes a partial tender or partial exchange
offer for the Underlying Stock. Consequently, this could affect the value of the securities and any payments on the securities. See &ldquo;General
Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment Events&rdquo; in the accompanying
product supplement for a description of the general circumstances in which the calculation agent will make adjustments to the adjustment
factor of the Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities May Become Linked To The Common
Stock Of A Company Other Than The Original Underlying Stock Issuer </B>&mdash; Following certain corporate events relating to the Underlying
Stock, such as a stock-for-stock merger where the Underlying Stock Issuer is not the surviving entity, the shares of a successor corporation
to the Underlying Stock Issuer will be substituted for the Underlying Stock for all purposes of the securities. Following certain other
corporate events relating to the Underlying Stock in which holders of the Underlying Stock would receive all of their consideration in
cash and the surviving entity has no marketable securities outstanding or there is no surviving entity (including, but not limited to,
a leveraged buyout or other going private transaction involving the Underlying Stock Issuer, or a liquidation of the Underlying Stock
Issuer), the common stock of another company in the same industry group as the Underlying Stock Issuer will be substituted for the Underlying
Stock for all purposes of the securities. In any such event, the equity-linked nature of the securities would be significantly altered.
See &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment Events&rdquo;
in the accompanying product supplement for a description of the specific events that can lead to these adjustments and the procedures
for selecting a replacement stock. The occurrence of such events and the consequent adjustments may materially and adversely affect the
value of the securities and any payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Historical Performance Of The Underlying
Stock Is Not An Indication Of Its Future Performance &mdash;</B> The historical performance of the Underlying Stock should not be taken
as an indication of the future performance of the Underlying Stock. It is impossible to predict whether the stock closing price of the
Underlying Stock will fall or rise during the term of the securities, in particular in the environment in the last several years, which
has been characterized by volatility across a wide range of asset classes. Past fluctuations and trends in the price of the Underlying
Stock are not necessarily indicative of fluctuations or trends that may occur in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to Conflicts
of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Potentially Inconsistent Research, Opinions
Or Recommendations By Barclays Capital Inc., WFS Or Their Respective Affiliates</B> &mdash; Barclays Capital Inc., WFS or their respective
affiliates may publish research from time to time on financial markets and other matters that may influence the value of the securities
or express opinions or provide recommendations that are inconsistent with purchasing or holding the securities. Any research, opinions
or recommendations expressed by Barclays Capital Inc., WFA or their respective affiliates may not be consistent with each other and may
be modified from time to time without notice. You should make your own independent investigation of the Underlying Stock and the merits
of investing in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We, Our Affiliates And Any Other Agent And/Or
Participating Dealer May Engage In Various Activities Or Make Determinations That Could Materially Affect Your Securities In Various Ways
And Create Conflicts Of Interest</B> &mdash; We, our affiliates, WFS and any dealer participating in the distribution of the securities
(a &ldquo;<U>participating dealer</U>&rdquo;) may play a variety of roles in connection with the issuance of the securities, as described
below. In performing these roles, our economic interests and the economic interests of our affiliates, WFS and any participating dealer
are potentially adverse to your interests as an investor in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In connection with
our normal business activities and in connection with hedging our obligations under the securities, we and our affiliates make markets
in and trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment
banking and other financial services with respect to these financial instruments and products. These financial instruments and products
may include securities, derivative instruments or assets that may relate to the Underlying Stock. In any such market making, trading and
hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions that are inconsistent
with, or adverse to, the investment objectives of the holders of the securities. We and our affiliates have no obligation to take the
needs of any buyer, seller or holder of the securities into account in conducting these activities. Such market making, trading and hedging
activity, investment banking and other financial services may negatively impact the value of the securities. Participating dealers may
also engage in such activities that may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, the
role played by Barclays Capital Inc., as the agent for the securities, could present significant conflicts of interest with the role of
Barclays Bank PLC, as issuer of the securities. For example, Barclays Capital Inc. or its representatives may derive compensation or financial
benefit from the distribution of the securities and such compensation or financial benefit may serve as an incentive to sell the securities
instead of other investments. Furthermore, we and our affiliates establish the offering price of the securities for initial sale to the
public, and the offering price is not based upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Furthermore, if any
dealer participating in the distribution of the securities or any of its affiliates conducts hedging activities for us in connection with
the securities, that participating dealer or its affiliates will expect to realize a projected profit from such hedging activities, and
this projected profit will be in addition to any selling concession and/or any fee that the participating dealer realizes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">for the sale of the
securities to you. This additional projected profit may create a further incentive for the participating dealer to sell the securities
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition to the
activities described above, Barclays Bank PLC will also act as the calculation agent for the securities. As calculation agent, we will
determine any prices of the Underlying Stock and make any other determinations necessary to calculate any payments on the securities.
In making these determinations, we may be required to make discretionary judgments, including those described in the accompanying product
supplement and under &ldquo;&mdash;Risks Relating to the Underlying Stock&rdquo; above. In making these discretionary judgments, our economic
interests are potentially adverse to your interests as an investor in the securities, and any of these determinations may adversely affect
any payments on the securities. Absent manifest error, all determinations of the calculation agent will be final and binding, without
any liability on the part of the calculation agent. You will not be entitled to any compensation from Barclays Bank PLC for any loss suffered
as a result of any determinations made by the calculation agent with respect to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Estimated
Value of the Securities and the Secondary Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Will Not Be Listed On Any Securities
Exchange And We Do Not Expect A Trading Market For The Securities To Develop</B> &mdash; The securities will not be listed on any securities
exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make a secondary market for the securities but are
not required to do so, and may discontinue any such secondary market making at any time, without notice. Even if there is a secondary
market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Because other dealers are not likely
to make a secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the
price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are willing to buy the securities. The securities
are not designed to be short-term trading instruments. Accordingly, you should be willing and able to hold your securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Value Of The Securities Prior To Maturity
Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways</B> &mdash; Structured notes, including the securities,
can be thought of as securities that combine a debt instrument with one or more options or other derivative instruments. As a result,
the factors that influence the values of debt instruments and options or other derivative instruments will also influence the terms and
features of the securities at issuance and their value in the secondary market. Accordingly, in addition to the price of the Underlying
Stock on any day, the value of the securities will be affected by a number of economic and market factors that may either offset or magnify
each other, including:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the expected volatility of the Underlying Stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the market prices of, and dividend rates on,
the Underlying Stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">supply and demand for the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a variety of economic, financial, political,
regulatory and judicial events; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our creditworthiness, including actual or anticipated
downgrades in our credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Expected To Be Lower Than The Original Offering Price Of Your Securities</B> &mdash; The estimated value of your securities on the pricing
date is expected to be lower, and may be significantly lower, than the original offering price of your securities. The difference between
the original offering price of your securities and the estimated value of the securities is expected as a result of certain factors, such
as any sales commissions, selling concessions, discounts, commissions or fees expected to be allowed or paid to Barclays Capital Inc.,
another affiliate of ours, WFS or its affiliates or other non-affiliated intermediaries, the estimated profit that we or any of our affiliates
expect to earn in connection with structuring the securities, the estimated cost that we may incur in hedging our obligations under the
securities, and estimated development and other costs that we may incur in connection with the securities.&#9;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Might
Be Lower If Such Estimated Value Were Based On The Levels At Which Our Debt Securities Trade In The Secondary Market</B> &mdash; The estimated
value of your securities on the pricing date is based on a number of variables, including our internal funding rates. Our internal funding
rates may vary from the levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the
estimated values referenced above might be lower if such estimated values were based on the levels at which our benchmark debt securities
trade in the secondary market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of The Securities Is Based
On Our Internal Pricing Models, Which May Prove To Be Inaccurate And May Be Different From The Pricing Models Of Other Financial Institutions</B>
&mdash; The estimated value of your securities on the pricing date is based on our internal pricing models, which take into account a
number of variables and are based on a number of subjective assumptions, which may or may not materialize. These variables and assumptions
are not evaluated or verified on an independent basis. Further, our pricing models may be different from other financial institutions&rsquo;
pricing models and the methodologies used by us to estimate the value of the securities may not be consistent with those of other financial
institutions that may be purchasers or sellers of securities in the secondary market. As a result, the secondary market price of your
securities may be materially different from the estimated value of the securities determined by reference to our internal pricing models.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Not A Prediction Of The Prices At Which You May Sell Your Securities In The Secondary Market, If Any, And Such Secondary Market Prices,
If Any, Will Likely Be Lower Than The Original Offering Price Of Your Securities And May Be Lower Than The Estimated Value Of Your Securities</B>
&mdash; The estimated value of the securities will not be a prediction of the prices at which Barclays Capital Inc., other affiliates
of ours or third parties may be willing to purchase the securities from you in secondary market transactions (if they are willing to purchase,
which they are not obligated to do). The price at which you may be able to sell your securities in the secondary market at any time will
be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades,
and may be substantially less than our estimated value of the securities. Further, as secondary market prices of your securities take
into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs related
to the securities such as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market
prices of your securities will likely be lower than the original offering price of your securities. As a result, the price at which Barclays
Capital Inc., other affiliates of ours or third parties may be willing to purchase the securities from you in secondary market transactions,
if any, will likely be lower than the price you paid for your securities, and any sale prior to the stated maturity date could result
in a substantial loss to you.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Temporary Price At Which We May Initially
Buy The Securities In The Secondary Market And The Value We May Initially Use For Customer Account Statements, If We Provide Any Customer
Account Statements At All, May Not Be Indicative Of Future Prices Of Your Securities</B> &mdash; Assuming that all relevant factors remain
constant after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market
(if Barclays Capital Inc. makes a market in the securities, which it is not obligated to do) and the value that we may initially use for
customer account statements, if we provide any customer account statements at all, may exceed our estimated value of the securities on
the pricing date, as well as the secondary market value of the securities, for a temporary period after the initial issue date of the
securities. The price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market and the value that
we may initially use for customer account statements may not be indicative of future prices of your securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Hypothetical
Examples and Returns</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate the maturity payment amount for a $1,000 principal amount security on a hypothetical offering of securities under various
scenarios, with the assumptions set forth in the table below. Terms used for purposes of these hypothetical examples do not represent
the actual starting price, threshold price or ending price applicable to the securities. The actual maturity payment amount and resulting
pre-tax total rate of return will depend on the actual terms of the securities. You should not take these examples as an indication or
assurance of the expected performance of the securities. These examples are for purposes of illustration only. The values used in the
examples may have been rounded for ease of analysis. The examples below do not take into account any tax consequences from investing in
the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 95%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: Black 1pt solid; width: 36%; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Contingent Fixed Return: </B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 64%; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">36.00% of the principal amount or $360.00 per security (the lowest possible contingent fixed return that may be determined on the pricing date)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Starting Price: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Threshold Price: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-family: Frutiger 65 Bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">$75.00 (75% of the hypothetical starting price)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The hypothetical starting price of $100.00 has
been chosen for illustrative purposes only and does not represent the actual starting price. The actual starting price will be the stock
closing price of the Underlying Stock on the pricing date, the actual threshold price will be 75% of the actual starting price and the
actual ending price will be the stock closing price of the Underlying Stock on the calculation day. For historical closing prices of the
Underlying Stock, see the historical information set forth under the section titled &ldquo;The Common Stock of Micron Technology, Inc.&rdquo;
below. We cannot predict the stock closing price of the Underlying Stock on any day during the term of the securities, including on the
calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 335px; width: 557px"></FONT></P>

<P STYLE="font: 10pt Georgia, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Georgia, Times, Serif; width: 85%; border-collapse: collapse">
  <TR>
    <TD STYLE="border: Black 1pt solid; width: 29%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
ending price</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 26%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
stock return</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 24%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 21%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical pre-tax total rate of return</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$175.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$140.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$136.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$130.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$120.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$110.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$105.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$90.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$80.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">-20.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$75.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-25.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,360.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$74.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-26.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$740.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-26.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$70.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">-30.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">$700.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">-30.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$600.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-40.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$500.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$250.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Hypothetical Examples</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1. Maturity payment amount is greater
than the principal amount and reflects a return that is equal to the contingent fixed return, which is greater than the percentage increase
in the stock closing price of the Underlying Stock from the hypothetical starting price to the hypothetical ending price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $110.00<BR>
Hypothetical threshold price: $75.00<BR>
Hypothetical stock return: 10.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Because
the hypothetical ending price is greater than or equal to the hypothetical threshold price, the maturity payment amount per security would
be equal to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">$1,000 +
the contingent fixed return of $360.00;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">= $1,360.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">On the stated
maturity date, you would receive $1,360.00 per security, which is the maximum maturity payment amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. Maturity payment amount is greater
than the principal amount and reflects a return equal to the contingent fixed return, which is less than the percentage increase in the
stock closing price of the Underlying Stock from the hypothetical starting price to the hypothetical ending price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $150.00<BR>
Hypothetical threshold price: $75.00<BR>
Hypothetical stock return: 50.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price is greater
than or equal to the hypothetical threshold price, the maturity payment amount per security would be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + the contingent fixed return of $360.00;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,360.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,360.00 per security, which is the maximum maturity payment amount. Even though the Underlying Stock increased by 50% from the hypothetical
starting price to the hypothetical ending price in this example, your return is limited to the contingent fixed return of 36.00%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3. Maturity payment amount is greater
than the principal amount and reflects a return equal to the contingent fixed return, even though the ending price is less than the starting
price but is greater than the threshold price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $95.00<BR>
Hypothetical threshold price: $75.00<BR>
Hypothetical stock return: -5.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price is greater
than or equal to the hypothetical threshold price, the maturity payment amount per security would be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + the contingent fixed return of $360.00;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,360.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,360.00 per security, which is the maximum maturity payment amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 4. Maturity payment amount is less
than the principal amount:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting price: $100.00<BR>
Hypothetical ending price: $50.00<BR>
Hypothetical threshold price: $75.00<BR>
Hypothetical stock return: -50.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price is less
than the hypothetical starting price by more than 25%, you would lose a portion of the principal amount of your securities and receive
the maturity payment amount equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; stock return)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 + ($1,000 &times; -50.00%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $500.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$500.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">The
Common Stock of Micron Technology, Inc.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, Micron
Technology, Inc. designs, develops and manufactures memory and storage products. Information filed by Micron Technology, Inc. with the
SEC under the Exchange Act can be located by reference to its SEC file number: 001-10658. The Underlying Stock is listed on The Nasdaq
Stock Market under the ticker symbol &ldquo;MU.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We urge you to read the following section in the
accompanying prospectus supplement: &ldquo;Reference Assets &mdash; Equity Securities &mdash; Reference Asset Issuer and Reference Asset
Information.&rdquo; Companies with securities registered under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
are required to file financial and other information specified by the SEC periodically. Such information can be reviewed electronically
through a website maintained by the SEC at http://www.sec.gov. Information filed with the SEC by the Underlying Stock Issuer can be located
by reference to its SEC file number provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The brief description of the Underlying Stock
Issuer included above has been obtained from publicly available sources. Information from outside sources is not incorporated by reference
in, and should not be considered part of, this pricing supplement or any accompanying prospectus or prospectus supplement. We have not
independently verified the accuracy or completeness of the information contained in outside sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing prices of the Underlying
Stock displayed in the graph below from Bloomberg Professional<SUP>&reg;</SUP>&nbsp;service without independent verification. The historical
performance of the Underlying Stock should not be taken as an indication of the future performance of the Underlying Stock. Future performance
of the Underlying Stock may differ significantly from historical performance, and no assurance can be given as to the closing prices of
the Underlying Stock during the term of the securities, including on the calculation day. We cannot give you assurance that the performance
of the Underlying Stock will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices
of the Underlying Stock for the period from January 1, 2020 to November 12, 2025. The closing price on November 12, 2025 was $244.90.
<I>The closing prices below may reflect adjustments in response to certain corporate actions, such as stock splits, public offerings,
mergers and acquisitions, spin-offs, extraordinary dividends, delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Georgia, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><IMG SRC="image_003.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">* The dotted line indicates a hypothetical threshold price of 75% of the closing price of the Underlying Stock on November 12, 2025. The actual threshold price will be equal to 75% of the starting price.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common Stock of Micron Technology, Inc. due December 7, 2026</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; background-color: #4F81BD">Tax
Considerations</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">You should
review carefully the sections in the accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax
Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax
Consequences to Non-U.S. Holders.&rdquo; The following discussion, when read in combination with those sections, constitutes the full
opinion of our special tax counsel, Davis Polk &amp; Wardwell LLP, regarding the material U.S. federal income tax consequences of owning
and disposing of the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Based on
current market conditions, in the opinion of our special tax counsel, it is reasonable to treat the securities for U.S. federal income
tax purposes as prepaid forward contracts with respect to the Underlying Stock. Assuming this treatment is respected, if you are a U.S.
holder, upon a sale or exchange of the securities (including redemption at maturity), you should recognize capital gain or loss equal
to the difference between the amount realized on the sale or exchange and your tax basis in the securities, which should equal the amount
you paid to acquire the securities. This gain or loss on your securities should be treated as long-term capital gain or loss if you hold
your securities for more than a year, whether or not you are an initial purchaser of the securities at the original issue price. The deductibility
of capital losses is subject to limitations. However, the IRS or a court may not respect this treatment, in which case the timing and
character of any income or loss on the securities could be materially and adversely affected. In addition, in 2007 the U.S. Treasury Department
and the IRS released a notice requesting comments on the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the
term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect
to these instruments; the relevance of factors such as the nature of the underlying property to which the instruments are linked; the
degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax;
and whether these instruments are or should be subject to the &ldquo;constructive ownership&rdquo; regime, which very generally can operate
to recharacterize certain long-term capital gain as ordinary income and impose a notional interest charge. While the notice requests comments
on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these
issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect.
You should consult your tax advisor regarding the U.S. federal income tax consequences of an investment in the securities, including possible
alternative treatments and the issues presented by this notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Treasury
regulations under Section 871(m) generally impose a withholding tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity
linked instruments.&rdquo; A recent IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that
do not have a &ldquo;delta of one&rdquo; with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income
tax purposes (each an &ldquo;Underlying Security&rdquo;). Based on our representation that the securities do not have a &ldquo;delta of
one&rdquo; within the meaning of the regulations, our special tax counsel believes that these regulations should not apply to the securities
with regard to non-U.S. holders, and we have determined to treat the securities as not being subject to Section 871(m). Our determination
is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend
on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security. If necessary,
further information regarding the potential application of Section 871(m) will be provided in the pricing supplement for the securities.
You should consult your tax advisor regarding the potential application of Section 871(m) to the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Non-U.S.
holders should also discuss with their tax advisors the estate tax consequences of investing in the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  J +,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:DS16/KV
MIR6$<:0L%D?)+$9P!51BY.R(G-0CS,TYKJ"WP)IHX\_WF J1'5U#(P*GH0>M
M<)K6I6M]HF;GRGO\[0P'( -$?BC[%X5C2UF1;R/"[7&>,UO]6E:YQ?VA34G%
MG>49K \(Z^^NZ>[3@">%MK[>A]#4/C+4[O3+:W>SE,;,Y5N <C'O6*IOFY3J
M=>*I^TZ'2Y%%<)?7_B'2+>*ZFNHI8G(XVCC(S@\5V5E=?:["&XQM\V,/CTR*
M<Z;BKDTL1&HVK6L6<CUHS7#W/B>Y3Q7Y,<_^@K,(V7 P>QY^M=A=.4LI64E6
M",01V.*)4W&U^HZ>(C4O;H6,CUHS7 :;?^(=4LYKF"\3$1P591ECC/'%;OA;
M79=4L9C=[?,A8 N!@$$9S3E1<5<SIXN,W:UCHLBC(]:XW^U]4\0ZA+#H\BV]
MK$>9F&2?_P!?I5[2H=:M=4>+4+DSVQB+(X'&[(_6DZ;6[*6)3>BT.DR**Y/P
MGJM]J.HW:W=P9(X1A1M YR?\*ZF:58HF=SA5&2?05,H.+L:4ZJG'F0_-&1ZU
MQ/AWQ)>7VO-!<3;H)0YC4J!CN/TJQK^J:AHNM6\WGLUC*1F,J./[PS].:MT9
M*7*9+%P<.=;'79%&17/^)-7DM-.B%C)_I4[JL.T9SZ_Y]ZS-0U75(;BTTF"=
M6O9%!EF8#@GL/88I1I-CGBHQ.SR/6EKE[*TUZTU2V^TWOVBT=CYF!TX.,UU%
M3*-GN:TY\ZO:P4445)H%<5XXD>*ZMF4X!4C]:[6L3Q+HPU>Q5 Q1XW#;@,G;
M_%@>N*VH34)J3.7&TI5:3C'<\UDD+9)-4YGZUI:S$MBRVY 68DRR)G/EY^ZG
MU '/N:KZ1!%J%R]LRAI3MDC7.#)M/S(/<C./I7L2K+DYCY:.'E[3DZG5?#$$
MQ:BW;>@_0U;\?G,5DG<R,?T_^O6QX8T)-!TUH5?>TDC2%B,<'H/P&*P?'<RK
MJ%@C'[F7(]LC_"O*C)2K71]#4@Z>%464M7.I(;=M<@+62L/D@8 $^YKJ;S6(
M+7PXU[;$>68QY0QW/ &/\]*Y_7-?BUJS6PTV&6:21@2=F,8J/[-]IO-,\/L^
MY8!YEQM/?KC\,_K5R2DDY:&$).#:AK<HW]M;P^';1XYXGNQ(7D"L"V6_PP*[
M=KP7'AIKG/W[8M_X[6?J7A+3X]+N&M+8+.(R4;))!'-9>E:FK>";V)F&^W1D
MQ[-T_F12DU.*:Z,J$949-2ZHQ]/UBZTW26MH8E1;AS^_;/' !Q]*Z3^S1H7A
M"\\N022R1EFD7H<\#'MBJNBZ2FK^#VAX$@D8HW]UATINA7;7NGW.@7AV3!62
M/=_+\#^E7-I[='J94X2BO>ZK0U/ T2IH0<8W/(Q/X<?TKHI?EB8^@S7 Z%KK
M>''FL=1A<(&)&!RI[_4&N@BU\ZG:W4\,#1V<,3'S9.-[8Z >E8U8/GOT.RA6
MA[+EZHSO (W&_D]77^IK1\8ZA]GTH6T;!9;IO+!)Z+W/^?6N=\*Z_9Z/:SI=
M;]\CAAM7/&*NV?E>,-?DEG1OLEO%M6,G!))ZG'XU<H^_S/8RIU;T53CNRC?&
MUTS6=+FLYHW2)55RC ]#@D_4$UT_BRR%[H$K 9>']XOX=?TS63XH\-V=CHS3
MV, C:-P6())V]*NOJ:W7@>2YW#=Y!1N?XNF*'+FY9(4(.'/3DNAG>$H)=4ND
MO;H[H[-!#"#Z^OY5:\5Z%<RW*:EI^XS1@!E7[W'1A_A5CP,!_8.1U\ULT?\
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CD([LH-6**+@XI[HCCACB4+&H51T"C J2BB@:5@HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $Q K8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BN7\9>*
M)M#A@L].CCEU6[SY7F<I"@QND<#D@9  [DXX&2/.KJP74W,NL33:G*>2;MMZ
MC_=C^XH]@!5Q@Y$2FHGMM%>$_P#"-Z%_T!=._P# 5/\ "C_A&]"_Z NG?^ J
M?X57LGW(]LNQ[M17A/\ PC>A?] 73O\ P%3_  H_X1O0O^@+IW_@*G^%'LGW
M#VR['NU%>$_\(WH7_0%T[_P%3_"C_A&]"_Z NG?^ J?X4>R?</;+L>[45X3_
M ,(WH7_0%T[_ ,!4_P */^$;T+_H"Z=_X"I_A1[)]P]LNQ[M17A/_"-Z%_T!
M=._\!4_PH_X1O0O^@+IW_@*G^%'LGW#VR['NU%>$_P#"-Z%_T!=._P# 5/\
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MGT4>UD%AG_"97/\ T*.N?]_+/_Y(H_X3*Y_Z%'7/^_EG_P#)%/HH]K(+#/\
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M,_X3*Y_Z%'7/^_EG_P#)%'_"97/_ $*.N?\ ?RS_ /DBGT4>UD%AG_"97/\
MT*.N?]_+/_Y(H_X3*Y_Z%'7/^_EG_P#)%/HH]K(+#/\ A,KG_H4=<_[^6?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO$<FJH;)O-F%PSRV"-<A]H!VS9^53C)&W/+8(R,.@\)R%5^UWZ2.FH27JM#
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M?_&O+[C_ (^=+_["MA_Z515[0P#*5.<$8X.#6=1M/0TI)-:F/_PBNC?\^?\
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MDC # 'H.1Q5Z_N+.ZN?%EW%XENU%C$9(8H-381KN@'. V0-Y&,$ $8'4@OE
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG!T5V&A>%/#FJ:3%=ZAH&E7=RY(::XLXY'.#@98@GI6E_P ()X/_ .A4T/\
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M_H3]8_[_ -G_ /)%'VS6_P#H3]8_[_V?_P D5W%%'LHA<X?[9K?_ $)^L?\
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M?_P27G_QJBX'2T5S7_">:'_<U?\ \$EY_P#&J/\ A/-#_N:O_P""2\_^-47
MZ6BN:_X3S0_[FK_^"2\_^-4?\)YH?]S5_P#P27G_ ,:HN!TM%<U_PGFA_P!S
M5_\ P27G_P :H_X3S0_[FK_^"2\_^-47 Z6BN:_X3S0_[FK_ /@DO/\ XU1_
MPGFA?Q'5$']Z32+M!^9BQ1<#I:*R],\1Z-K$ABT_4K>>9?O0A\2+]4/S#\16
MI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!5U'4+;2M/GOKR41V\*[G8
M\_@!W)/  Y)(%<5/]O\ $X\[5_-M+!A^[TM),97UG8?>/^P#M'0[NM6M;F.L
M>+%LSS9Z0%E=>SW+C*Y_W$.?K(#V%6:B4N@TB*WMH+2%8;:&.&)>B1J%4?@*
MEHHK,H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@"I?:78ZFBK>6T<I7E'(PR'U5ARI]P0:++6[WPY-%!JD\E[I$CA%O
M92#+:D\ 2G^),X&_J,_-D?,+=-DC2:)XI45XW4JRL,A@>H(IIV%8ZZBN7\%W
M4D=M=Z'.Y>33'5(G8Y+V[#,1)]1ADSWV9[UU%;$A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >?Z,WFR:M<GEIM4N@3Z^7*8A^D8'X5J5E:!_QZ7W_85U#_ -*Y
MJU:Q>Y:"BBLZ?7+"VUF#297F%[.ADC06\C*RCJ=X7;QQGGN/44@-&BJ>FZG:
MZM:?:;0RF+>R9E@>([E.",. >#QTZ@^E7* "BBJ>HW[6$<3)8W=X\LGEJEL@
M)!VLV6+$!1\N,D@9(]: +E%8>B>*+;79Q%!:7<&ZUCNT:<)AT<D#&UB<@J0<
MXZ=QS6Y0 4444 %%5A>9U)[+[/<#;"LOGE/W1R2-H;NPQDCT(]:LT %%%% !
M1110 4444 %%5K^\^PVAN/L]Q<89%\NW3>YW,%SCT&<D]@":=:7EO?1R/;R;
MUCE>%C@C#HQ5ASZ$&@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** *VE-Y7Q B4<?:=+E+>_E2
MQX_+SC^9KM:XFP_Y*'IO_8*O?_1MK7;5K'8EA1115""BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#S[0/^/2^_P"PKJ'_ *5S5JUE:!_QZ7W_ &%=0_\ 2N:M6L7N6%<M
MXZ20:3:W-K'>F_M[N)K=[.!Y70%@LG"J>/++]>,X[XKJ:*0'G^OZ;)+<WJPZ
M?-)/)9P)H4PM786LB[L_-@^202A);;D ==N!%J-FMKXEO"=(N79M6M+R*:"P
M=U"A4$CAE4@'(;(SGOTYKT6BG<#E/%&@#4-6L;B&U#-=1R:==RHHWI XW%MW
M;&UE'O)[UC&Q^S+H^M:CHTG]K_;E^U3V]B\TNR.-HRQ**3M8@,/9AUQ7HE%%
MP//O ?G)J%K'-8W\!CT>&!FN+*6)1(LDA9=S*!G#+WY_ U'J6A+>W_BNXT_3
M[B/5%&ZSF\B2(-F())L;Y58M\PX/)P<\ CT6BBX'G,&ESQ>';M88)I=/DOX)
MI[.#2Y+1?)&T2HD+,7((4,PQALL!NR14.NZ(LZ6,-A9SVFBFVG2!9-,FN6@F
M=P0ZQJP:)N3M9AA<$87(KTRBBXCSW6=%&H:U=.-+:6_CT^WN4EELR%EN8G+!
M2^"I8C"GYCP2!G%5?$'AV66:!UM%MK:]AGEDV:8]TT-U(RD-MB8;9 O D.0"
MIZ;N?3**+C.'\3P:<VKZ ^LZ8]_NM;A)$6S,[L0J'E4#=\^H!.<]ZQ%T37/M
MFG?VH9?M,=K9_9YEL'NI(W1B702JX6)CP&9N&!ZG%>BW&DVEUJ5KJ$JS?:;4
M$1,L\BJ >N5#!3G Z@]!5ZBXCD=)TG3Y/&^L7[:=-'<Q3*\$[021H<Q!'*D@
M*V3G/7. >P-<S<:5>2+J#6%D[PR3I+=O<:5*D[(9MS1R#(^T@#/W#DJI4YW#
M/JE%%QGFD&BQA;.#5[&\U'1C'<"WBBT^6(0RO(&7$6XO$ "RJS8V@'E003+?
MVBVWB.Z)T:[W/JUG>1216+R!5V()&WJI .0<\Y/7D<UZ-11<#S"31-,72-2O
MTT.Z^W)J9\G_ (E\VX1FX5P43;TV@G('&3_>.9;71++3XI+^R\/I'J6FZN\J
M+]B\GSH9)6551RH#81P0 >"JCBO2JK7%A;W5S!/,)&: DHOFL$SZE =K$8R"
M0<'D8HN(Q]*TK2])UI+:TTN6"XCL IN8HRMN4,C$H,':'W$MC&<'KBNAHHI#
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH JV'_)0]-_[!5[_P"C;6NVKB;#_DH>F_\ 8*O?_1MK7;5K
M'8EA1115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#S[0/^/2^_["NH?^E<U:M96@?\
M>E]_V%=0_P#2N:M6L7N6%->1(UW2.J+D#+' R3@?K3JY/QW#J#V-G);137%G
M'.INH+:X:&9LLNTJ01G'/RY&20>U(#K**Y;2];E:XT"TM2;C3KRU=UN[J0FX
M8HHX==H /(R<G//'>IM3U?4O[2O[733:1C3K1+F;[3$S^<7WX12K+LXC.6(;
M[W3CEV Z.BN+_P"$OOKG3;O7+6.W33;)HEEMI8F::7<D;L0X8!<"4  J<E>H
MSQ9B\1Z@YMM186W]F7.HM8);B)O.3$C1!R^[!RRYV[1@'KD<E@.KHK/UK54T
M?3);IHYG8*VP16\DWS $C<$!(''4X'O6=J'B/RO!>H:U:Q3"2VMGD5;BVDB^
M<+D?*X!*Y(YZ>](#?>1(UW2.J+D#+' R3@?K3JXGQ5IVI6FAZ='"]YJ%M#,I
MO52[:.XE8NN&5@1G!+?)E1R,8VBKNEZW*UQH%I:DW&G7EJ[K=W4A-PQ11PZ[
M0 >1DY.>>.].P'4T5SFIZOJ7]I7]KIIM(QIUHES-]IB9_.+[\(I5EV<1G+$-
M][IQSG?\)??7.FW>N6L=NFFV31++;2Q,TTNY(W8APP"X$H !4Y*]1G@L!VE%
M<I%XCU!S;:BPMO[,N=1:P2W$3><F)&B#E]V#EESMVC /7(YW]2O3IUI]J\H2
M1HP\P;]I"GC*_P!XYQQQGMS@% 7**R7U2[E\.W&I6=FLDWE/);PJX<N /ESC
M S_L@^V:Y>+7=6N-8TZY.I6[6T4%VUQ EC-"S>68R0T;R95\, ,@XY/S!AAV
M [ZBN*;Q?J%A9BXOH;:<W.F'4+:.!&3R\%!Y;L6;=S*OS +T/R\@5%XEEO=.
ML]-U/7$LY[FSU'=!-8VSLWEF%\C822#D<@-@@ DCL6 [JBN;O=4U>S\'0:DL
MVFW%\QA9C'&_D.'=1A?G)QAA\W.<9QSBLN;Q3KMIJPTZ6UAN)[8P_:5M+&XD
M$HD<C*L,K%M0!COSDY QC)+ =Q17#7&J:[IM_P"(;H7MI-;P:A;1)!);N=J2
M"$84^9@8#\\<MD\9P+,^NZ\ 8;=]-,_]K-8!I('"[3'O5L!\Y'?U_P!GK18#
ML**XIO$'B&TOVCN_[+:*"]L[298HI-S&?8#M8OQM+]2#N'9<<[&B3S1:SK&E
M/-+-%:M%+"TK%F59%)*ECR<,K8SS@@=J+ ;M%%%( HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"K8?\E#TW_L%7O\
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M+G;P<Y#C<#M/7MC:-!=^(+BY%M=Z>EK8ZO<W*S0SF67S"'5 4V@!<N6SDY
MP,Y#$\(^)%@O0PL)9[R.S\R2;4II"9()2['+1'AL]!@+T IV0'=V'_)0]-_[
M!5[_ .C;6NVKB-/S_P +!TS< #_9-[D Y_Y:VM=O5QV$PHHHJA!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M68&K165_;]O_ - _7/\ P27G_P :H_M^W_Z!^N?^"2\_^-468&K165_;]O\
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8H **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %/ BT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#=HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3MW2LB,_]YLJ$)&0"K'O0!K>/O\ DG?B3_L&7'_HMJE\%?\ (A^'O^P9;?\
MHI:R?BCJ<VG> =62+3+N]%U9SPNUNH(@!C;]X^3PH[UK>"O^1$\/?]@RV_\
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ML.]\*:9>ZO;ZFT;I<1S^<Y5V E/EE!N&<="/RH R5\:72V7VB>PA7[18B^M
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M4@N="FM(B#F5GR!Q_NBDZ,TKO\U_F-58MV_1F[11161H%%%% !1110 4444
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M?\D[\2?]@RX_]%M4O@K_ )$/P]_V#+;_ -%+0!NT444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 4]3M+>[LG%Q;QS;%+*'C5\''8'BK
M,,:10I'&BHBC 51@#\*CO,?8I\XQL/7;Z?[7'Y\5,OW1]*=W:PK+<6BBBD,*
M*** *]]?6NF6,U[>S+!;0KNDE?H@]3[4RPU33]4A$VGWUM=QD9WP2JX_0U+=
MVD-]93VER@D@GC:.1#T92,$?E7@?A#X9ZKX U^;Q-J%BU_8V=S)&D,#GSEB'
M"W 4</QGY.O<=* />K0;4D^4#]ZY^Z!W]C^O6K%9^BWUIJ>G+?6,\<]K.S/'
M+&5PP)Z\?UY]>:T* "BBB@ HHHH **CGGBMXVDE; 4%NF20.N .35))KV^:"
M6%1;6A!,@F0^:W8 #HH[YZ^U $]W?P631))O:25MJ)&A9F/T'8>M5Y+.ZU&.
M6*^;R8"XV1V\A#,HSPS>_' Q]:LV5C!80F.!2 S;F9F+,Q]23U-6: &HBQKM
M10![4ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .(\6M<V6O6UQ;7EU&TD#;M]SY<*('C!( 4DD;MQ]E-;_ (58/X:L
MV /1LGS6ER=QR0YY8$\@^A]*Y_Q+-:Q:U(L&O7<E^57=I,<S%<8X/RD&/(SR
MQQ[5U>C[O[(MM\;QMLY1YA*5]BXZT 7:X[4[2?4?$K6KZ;<6]BDL<WGPQ _:
MI@N%=V!R$3CC&21Z#GL:* .#TOP]=WPL[6^M)[..QTH6+R97YY0Z,&3KD Q[
MLD?Q=.M+8Z5KNF:Q9-;?:/L\[!Y<["H!D8N)?0[6R-O&YCVKNZ* .,^*5A?7
MO@'5GL]5EL5@M)Y9U2)7^T((VS&<] ?4<UK>"O\ D1/#W_8,MO\ T4M1>/O^
M2=^)/^P9<?\ HMJE\%?\B'X>_P"P9;?^BEH W:*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** (+PXLIR2!A#R2!V]3Q^=3+]T?2H;QM
MME,V[;A"<[MN./7!Q^53+]T?2@!:*** "BBB@ HHHH XF?1K_0KRZUOPN@E6
M2=VOM),@V7'/+Q$<1R^W1NAYYKI-$UVP\0:<M[82EDR4DC==LD+CJCJ>58=P
M:M6C;DD^;=B5Q][=CGIT'Y5@:WX:N!J!U[P[+'::T !*C_ZF^0?P2@=_1QR/
M<<4 =/16+X?\2VVO1S1&*2SU&V(6[L)\"6!O?^\I[,."*N2:D&95LHC>,9"C
MF-QMCQUW'MUZ4 7))$B0O(ZHBC)9C@"J,EW<W3SV]E$T;(!BYF3]V2?[HSEN
M._2A=,,Y<ZC*+P&0.D;( D>,XP._7O6AT&!0!3@TZ&.X6[E_?7@0(9V'./8=
M%S[5<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** .7UG4-*M-7,5_H!F#IN-X\$95B,87<Q&3@_I6UHTZ7
M.D6\T=HMHC@E8%92$&3C[O'OQZU0UWPXNLW<%SYJ+)#&R*)8O,7.Y'5L9[,@
M!]02.*OZ/IW]E:3!9;U?R@>43:HR2<*.P&< >@% %ZBBHYV=;>5HAF0(2H]3
MCB@"2BO,+$7=_#8Q65[+.UQIJ7>I1O=LN^02)N4M_P LR<R#C'"X[5J^'M=O
M(]6M;"^!N))8HHA,92"1L=E<)CD'8Q+9S\RB@#8\??\ )._$G_8,N/\ T6U2
M^"O^1#\/?]@RV_\ 12UD_%*\U*U\ :LNGZ6+Y)K2>.Y8W"Q_9XC&V9,'[V/[
MHYK6\%?\B)X>_P"P9;?^BEH W:*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** (;L[;.8@XPAYR1CCU'(_"I5^Z/I45WG['-C.=AZ;O3
M_9Y_+FI5^Z/I0 M%%% !1110 4457O+ZVT^#SKF41H3M'!)8]@ .2: %M#E)
M.2<2N.6)[^X_^M3+C4(()3 I\VZV%U@0C<P'\OQJC +V^%W$=]I;%V"3*S>:
MWS<D!A\HQQ_*M*WM8K9 L:_,%"EV.68#ID]30!S6L>%[G7I+;54N/[)UFVC8
M0R0@/C)SLD/_ "T0]UZ=P:D\-:^DDQT'4;*+2]9MTW-:)_JID_YZ0G^)#^:]
M#73UDZ_X>L_$-FD5R9(IX6\RVNX6VRV\G9D;M[CH1P<T :U%<II/B&]L-2BT
M#Q0(X[^3(L[Z-=L%^!Z?W)/5/Q&1TZN@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .9\0W-XNMV%K$
MU^;5H)9)%T_9YFX% I.[G;@MT[XS6YIV?[/AS]ISM_Y><>9_P+'>L3Q1;V[7
M5G<OJMKI\T:.B/-.\98';D#;(N1P.N>U7O#%U->>&K&XG5A(Z$G<6.>3R"Q)
M(/4$]B* ->BBB@"&.TMHC*8[>)#,<R%4 WGU/K3OL\/G+-Y,?FJNQ7VC<%]
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MC"JHP *=110 4444 5;!0L4N% S-(>%4?Q'T)_,\^M6JJ6&/*FQC_7R=-O\
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M$6K'4/LR%A'&D49'R1[&9@0._+D\YP1D5*OA70EG:8:7;^82>=O3+!R!Z#<
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M% !1110!SOC[_DG?B3_L&7'_ *+:I?!7_(A^'O\ L&6W_HI:B\??\D[\2?\
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M<-R%1@N0OHN,#=7?VERE[9074081S1K(H88.",C/YT </_PIWPC_ ,\M1_\
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M S_[!TC[%]B_LRS^R[]_E>2NW=ZXQU]ZMFV@.,PQG"&,?*.%/5?IP./:I:*
M(;6TM[&V2WM((X($^['&H51] *FHHH *BN;6WO(&@N88YH6^\DBA@?P-2T4
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M%O"/*Q$@\H8CPH^3C''IQQ3+6RM;&)H[2VB@C9BY6) H+'J<#O4]% !1110
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M6QY)7T-6J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#U3PUX:T&;
MPKH\LNB::\CV4+,[6D9+$H,DG')K4_X17P[_ - '2_\ P#C_ ,*/"O\ R*&B
M?]>$'_HM:UZ ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^
M$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2_
M_ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\
M._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_
M\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A
M%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X
M_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T
M =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\
M"M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\
MT =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH
M_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =
M+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#
M(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T
M=+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X
M17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P
M#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R
M/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\
MP#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#
MO_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C
M_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\.
M_P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2__ ./
M_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\
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ME^<_DB<C!E\O.W?C^+&:L:[X3TGQ%+!/?13+<P*RQW%M.\,BJWWEW(0=I]*
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M - S5/\ P%- &M163_;R_P#0,U3_ ,!31_;R_P#0,U3_ ,!30!K45D_V\O\
MT#-4_P# 4T?V\O\ T#-4_P# 4T :U%9/]O+_ - S5/\ P%-']O+_ - S5/\
MP%- &M163_;R_P#0,U3_ ,!31_;R_P#0,U3_ ,!30!K45D_V\O\ T#-4_P#
M4T?V\O\ T#-4_P# 4T :U%9/]O+_ - S5/\ P%-']O+_ - S5/\ P%- &M16
M3_;R_P#0,U3_ ,!31_;R_P#0,U3_ ,!30!K45D_V\O\ T#-4_P# 4T?V\O\
MT#-4_P# 4T :U%9/]O+_ - S5/\ P%-']O+_ - S5/\ P%- &M163_;R_P#0
M,U3_ ,!31_;R_P#0,U3_ ,!30!K45D_V\O\ T#-4_P# 4T?V\O\ T#-4_P#
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M_P# 4T?V\O\ T#-4_P# 4T :U%9/]O+_ - S5/\ P%-']O+_ - S5/\ P%-
M&M163_;R_P#0,U3_ ,!31_;R_P#0,U3_ ,!30!K45D_V\O\ T#-4_P# 4T?V
M\O\ T#-4_P# 4T :U%9/]O+_ - S5/\ P%-3V.K0WUS);B"YAF1 Y2>(H2I)
M (_$&@"_1110 4444 >=_&7_ )%"T_Z_T_\ 1<E%'QE_Y%"T_P"O]/\ T7)1
M0!UOA7_D4-$_Z\(/_1:UKUD>%?\ D4-$_P"O"#_T6M:] !1110!2.D:>=1&H
M&SB^UC_EKMYSC&?KCC/7%10Z!I%O!<P1:=;K%<C$R!!AQZ'VY/'09K2HH KV
M5C:Z=;"WLX$AB!+;4'4GDD^I]ZQ]2_Y'G0/^O6\_]HUT%<_J7_(\Z!_UZWG_
M +1H Z"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK)&\,ABEBE7:\;C!P1]"#QV(K,U+_D>= _Z];S_VC0!T%%%% !1110 4444
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M)/\ Q-K\=?XD]<_W/P^E:-% &=_94N?^0M?_ /?2>N?[GX?2@:5*,?\ $VU
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M@#-_LJ7&/[7U#_OJ/TQ_<_'ZT'2I3G_B;:@,YZ-'QQC^Y^-:5% &:=*E.?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK<'G&?\ '^5 T8  ?VCJ/&/^7@^F/_K_ %H TZ*S/[&&,?VCJ/\ X$'TQ_\
M7^M!T8'/_$QU$9STN#W ']* -.BLQM&#9_XF.H#.>EP>,X_P_4TIT<$G_B8:
MASG_ )>#ZY_^M]* -*BLW^QQG/\ :&H?^!!]<_\ UOI0-& Q_P 3#4#C'6X/
M8D_UH TJ*S!HP&/^)CJ)QCK<'G&?\?Y4#1@ !_:.H\8_Y>#Z8_\ K_6@#3HK
M,_L88Q_:.H_^!!],?_7^M!T8'/\ Q,=1&<]+@]P!_2@#3HK,;1@V?^)CJ(SG
MI<'C./\ #]32G1@2?^)AJ'.>EP?7/_UOI0!I45F_V.,Y_M#4/_ @^N?_ *WT
MH&C $?\ $PU XQUN#V)/]: -*BLP:,!C_B8ZB<8ZW!YQG_']!0-&  _XF.HG
M&.MP>PQ_]?ZT :=%9G]C#&/[1U'_ ,"#Z8_^O]:#HP(/_$QU$9STN#W ']*
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M/4'-+7,:!8)=::2-1O\ <)9.%N>Q9@#^(Y^O-:AT8$'_ (F.HC.>EP>XQ_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA/3/][\/K0=6D&?^)3J!QGHB<X /][W_ $H TJ*S3JT@S_Q*M0.,]$3G&/\
M:]_TH.K2 G_B5:@<9_@3UQ_>_'Z4 :5%9O\ :LF<?V5J'_?">N/[WX_2@:M(
M<?\ $JU 9QU1.,DC^][?K0!I45FC5I#C_B4Z@,XZHG&<_P"UVQ^M U:0@?\
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M+3K=8KD8F39PX]/IR<#H,UI44 5[*QM=.MA;V<"0Q EMJCJ3R2?4^]8^I?\
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M]B:BFB1&.%=2<9P#VJ.ZN8[2W::5L*.!@9))X  [FIMT*N*]Q&L<C!U8Q@Y
M8=0.E<ZFD+!I9U*:>>6[;;<?/*2J-@8 '3 R?SJ:W\-65S!'<2K(LD\8>4!B
M"92!\_LW7\ZVGM8WLC:'/E[-F<\XQC\ZUYE#2+,K.6K1GZP]TUU:):IN,#&Y
MDPV"RJ"-@'<G=^E6='O'O],CN9%*L[/\I&" &( _(5!H^G7=H\US?W?VBXF"
MJ0%PJ[<CCZ\$^]4VU.ZM)+C3[:T,DZR/L9FP/G(*M[C+X/TIVNN5= O9\SZG
M0T57LKI+VRAN8]VV10?F&#^([5.2%&20!ZFL6K.QK>^HM%%%( HHHH ****
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M(UO*VC_:K&&-[N243J3QO&\E<GTP:AGT&_\ [,+QWWF:FLYNDD=?EW;"H3Z
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MCPK_ ,BAHG_7A!_Z+6M>@ HHHH ***PX_%-D]E<7IANEM(6*+,T8Q*P?8%0
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M .O&/_T8] &M1110 4444 >=_&7_ )%"T_Z_T_\ 1<E%'QE_Y%"T_P"O]/\
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M4@T: $?Z3?\ &/\ E\E]<_WJT:* ,X:- ,?Z3?\ &.MY+VS_ +7O0-&@&/\
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M"QP3M<?-@8(/'2K.J>);^;6;>RT.6Q*20M-!+,=\5\ZG#0HZMA6 !)SD].,
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M:O9Z7-<Z@_[D2(JF(QDC='/DC]V1DY&2I (P>O8T4 96CZ!::*)6ADN+B:7
M:>ZE,DA4?=7<>=H[#^M:M%% !1110!S_ (J@OQ9K>:?>^6\2NDEJ\HC2Y1AR
MH8_<D&,JW8]>#7->%/"R7EP-5>%(]+N8!LB# B\A(4PB6,KA3&HZ]2S,<XKO
M;VPL]2MC;7UK#=0,03'-&'4D=.#4ZJJ*%50JJ,  8 % "T444 %%%% '$^*M
M!74/$%C]ETVY,ERR"\N$PL+1*>K-G<LJ=48#.>,X)KI])TBVT>V:*!I99)&W
MRSSMODE;U9N_''T%7Z* "BBB@ KD/&Z36MI+?M=N^FF QW]AYH0O$.2\1/\
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M().VWYK=@20'&[>I&"0#C/-=M965MIUE%9VD2Q01+M1%[#_'W[U8HH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G?QE_Y%
M"T_Z_P!/_1<E%'QE_P"10M/^O]/_ $7)10!XW8^)M?BT^VCCUS4DC2)555NY
M %  P ,U8_X2KQ%_T']4_P# R3_&BB@ _P"$J\1?]!_5/_ R3_&C_A*O$7_0
M?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^$J\1?]!_5/\ P,D_QHHH /\
MA*O$7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&BB@ _P"$J\1?]!_5/_ R3_&C
M_A*O$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^$J\1?]!_5/\ P,D_
MQHHH /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&BB@ _P"$J\1?]!_5
M/_ R3_&C_A*O$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^$J\1?]!_
M5/\ P,D_QHHH /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&BB@ _P"$
MJ\1?]!_5/_ R3_&C_A*O$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^
M$J\1?]!_5/\ P,D_QHHH /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&
MBB@ _P"$J\1?]!_5/_ R3_&C_A*O$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_
M\#)/\:/^$J\1?]!_5/\ P,D_QHHH /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4
M_P# R3_&BB@ _P"$J\1?]!_5/_ R3_&C_A*O$7_0?U3_ ,#)/\:** #_ (2K
MQ%_T']4_\#)/\:/^$J\1?]!_5/\ P,D_QHHH /\ A*O$7_0?U3_P,D_QH_X2
MKQ%_T']4_P# R3_&BB@ _P"$J\1?]!_5/_ R3_&C_A*O$7_0?U3_ ,#)/\:*
M* #_ (2KQ%_T']4_\#)/\:/^$J\1?]!_5/\ P,D_QHHH /\ A*O$7_0?U3_P
M,D_QH_X2KQ%_T']4_P# R3_&BB@ _P"$J\1?]!_5/_ R3_&C_A*O$7_0?U3_
M ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^$J\1?]!_5/\ P,D_QHHH /\ A*O$
M7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&BB@ _P"$J\1?]!_5/_ R3_&C_A*O
M$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^$J\1?]!_5/\ P,D_QHHH
M /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&BB@ _P"$J\1?]!_5/_ R
M3_&C_A*O$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^$J\1?]!_5/\
MP,D_QHHH /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&BB@ _P"$J\1?
M]!_5/_ R3_&C_A*O$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/\:/^$J\1
M?]!_5/\ P,D_QHHH /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4_P# R3_&BB@
M_P"$J\1?]!_5/_ R3_&C_A*O$7_0?U3_ ,#)/\:** #_ (2KQ%_T']4_\#)/
M\:/^$J\1?]!_5/\ P,D_QHHH /\ A*O$7_0?U3_P,D_QH_X2KQ%_T']4_P#
MR3_&BB@ _P"$J\1?]!_5/_ R3_&C_A*O$7_0?U3_ ,#)/\:** ,GQ#K^LWNG
8QQW6K7\\8E#!9;EV .#S@GW-%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
